| Net Cash Provided by (Used in) Operating Activities |
-31.2M |
USD |
-122% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-123M |
USD |
-76.7% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-3.28M |
USD |
-1146% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
86M |
shares |
-8.12% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-157M |
USD |
-309% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
792M |
USD |
+17.2% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
3.4M |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
100M |
USD |
+5.56% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
88M |
USD |
+13.7% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
8.11M |
USD |
+26.3% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
7.39M |
USD |
+0.82% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
97M |
USD |
+5.78% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
32.6M |
USD |
+11.7% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |